Get the Stockscreener App
0.7598
3.85%
-0.0202
Dbv Technologies Adr stock is traded at $0.7598, with a volume of 53,845.
It is down -3.85% in the last 24 hours and up +7.14% over the past month.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.
See More
Previous Close:
$0.78
Open:
$0.782
24h Volume:
53,845
Relative Volume:
0.09
Market Cap:
$75.04M
Revenue:
-
Net Income/Loss:
$-72.73M
P/E Ratio:
-1.369
EPS:
-0.555
Net Cash Flow:
$-80.33M
1W Performance:
-8.54%
1M Performance:
+7.14%
6M Performance:
-43.77%
1Y Performance:
-63.59%
1-Day Range:
$0.75
$0.81
1-Week Range:
$0.75
$0.827
52-Week Range:
$0.5024
$2.14
Dbv Technologies Adr Stock (DBVT) Company Profile
Name
Dbv Technologies Adr
Sector
Industry
Phone
33(0)155427878
Address
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-04-23 | Upgrade | Societe Generale | Hold → Buy |
| Dec-16-22 | Downgrade | Goldman | Neutral → Sell |
| May-10-22 | Downgrade | Goldman | Buy → Neutral |
| Sep-14-21 | Upgrade | Societe Generale | Hold → Buy |
| Jan-22-21 | Downgrade | Societe Generale | Hold → Sell |
| Nov-02-20 | Upgrade | Societe Generale | Sell → Hold |
| Aug-06-20 | Downgrade | Societe Generale | Buy → Sell |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-17-20 | Downgrade | Stifel | Buy → Hold |
| Jan-09-20 | Upgrade | Stifel | Hold → Buy |
| Dec-16-19 | Initiated | Citigroup | Buy |
| Sep-05-19 | Resumed | Morgan Stanley | Equal-Weight |
| Jun-17-19 | Initiated | Goldman | Buy |
| Dec-20-18 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-20-18 | Downgrade | BofA/Merrill | Buy → Underperform |
| Dec-20-18 | Downgrade | Jefferies | Buy → Hold |
| Dec-20-18 | Downgrade | Stifel | Buy → Hold |
| Oct-31-17 | Upgrade | Societe Generale | Sell → Hold |
| Oct-24-17 | Downgrade | Societe Generale | Buy → Sell |
| Oct-23-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-23-17 | Initiated | Deutsche Bank | Buy |
| Mar-16-17 | Upgrade | Societe Generale | Hold → Buy |
| Sep-26-16 | Initiated | JMP Securities | Mkt Outperform |
| Dec-03-15 | Initiated | Barclays | Overweight |
| Oct-23-15 | Initiated | BofA/Merrill | Buy |
View All
Dbv Technologies Adr Stock (DBVT) Latest News
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - MSN
DBV Technologies (NASDAQ:DBVT) Receives New Coverage from Analysts at StockNews.com - MarketBeat
DBV Technologies (NASDAQ:DBVT) Research Coverage Started at StockNews.com - Defense World
European Equities Traded in the US as American Depositary Receipts Gain Wednesday - MSN
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading - MSN
HC Wainwright Forecasts Higher Earnings for DBV Technologies - Defense World
European Equities Traded in the US as American Depositary Receipts Rise Slightly Higher in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - MSN
Data-Based Insights About DBV Technologies ADR (DBVT) - Stocks Register
HC Wainwright Has Positive Forecast for DBVT FY2024 Earnings - MarketBeat
GSK Plc ADR (GSK): An Important Analyst Insights - Stocks Register
Paramount Global (NASDAQ: PARA): Blank Check On Growth? - Stocks Register
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading - MSN
H.C. Wainwright raises DBV Technologies shares price target, keeps Buy rating - Investing.com India
DBV Technologies (NASDAQ:DBVT) PT Raised to $7.00 - MarketBeat
DBV Technologies ADR (NASDAQ: DBVT) Is The Number One Stock Currently Moving. - Stocks Register
Atlantic Union Bankshares Corp Still Hasn’t Convinced Analysts? - Stocks Register
DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe - GlobeNewswire
DBV Technologies (NASDAQ:DBVT) Coverage Initiated by Analysts at StockNews.com - Defense World
StockNews.com Begins Coverage on DBV Technologies (NASDAQ:DBVT) - MarketBeat
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress - The Manila Times
Peanut Protein Patch Market Report to 2032 -DBV Technologies, Segment - IndiaPolitics.com
DBV Technologies (NASDAQ:DBVT) Now Covered by Analysts at StockNews.com - MarketBeat
DBV Technologies SA (DBVT) (Q2 2024) Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
European Equities Traded in the US as American Depositary Receipts Tread Water in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading - MSN
Point72 Asset Management L.P. Cuts Stock Position in DBV Technologies S.A. (NASDAQ:DBVT) - MarketBeat
European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading - MSN
Short Interest in DBV Technologies S.A. (NASDAQ:DBVT) Expands By 7.1% - MarketBeat
European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading - MSN
Wall Street SWOT: DBV Technologies stock faces pivotal phase in peanut allergy treatment - Investing.com
European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - MSN
Wall Street SWOT: DBV Technologies stock faces pivotal phase in peanut allergy treatment By Investing.com - Investing.com South Africa
DBV Technologies' (DBVT) Market Outperform Rating Reiterated at JMP Securities - MarketBeat
JMP Securities Reiterates "Market Outperform" Rating for DBV Technologies (NASDAQ:DBVT) - MarketBeat
JMP Securities Reiterates “Market Outperform” Rating for DBV Technologies (NASDAQ:DBVT) - Defense World
DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial - GlobeNewswire
(ADME) Pivots Trading Plans and Risk Controls - Stock Traders Daily
DEADLINE ALERT for ABR, FIVE, DXC, and INDV: The Law - GlobeNewswire
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading - MSN
Arkade Developers IPO Allotment Finalised: How to Check Status Online, Know GMP Today, Listing Date - News18
Arkade Developers IPO Allotment Today: A Step-by-Step Guide to Check Status Online, Know Latest GMP - News18
DBV Technologies S.A. (NASDAQ:DBVT) Short Interest Down 5.1% in August - Defense World
Arkade Developers IPO Day 3: Check Subscription Status, GMP, Review - News18
Dbv Technologies Adr Stock (DBVT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Dbv Technologies Adr Stock (DBVT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Mohideen Pharis | Chief Medical Officer |
May 24 '24 |
Sale |
1.36 |
660 |
898 |
81,152 |
| Mohideen Pharis | Chief Medical Officer |
May 22 '24 |
Sale |
1.38 |
382 |
527 |
81,812 |
| Tasse Daniel | CHIEF EXECUTIVE OFFICER |
Mar 08 '24 |
Buy |
0.83 |
17,094 |
14,188 |
17,094 |
| Ndu Adora | Director |
Feb 06 '24 |
Buy |
0.89 |
1,825 |
1,624 |
1,825 |
| Mohideen Pharis | Chief Medical Officer |
Nov 22 '23 |
Sale |
1.74 |
2,245 |
3,906 |
82,194 |
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):